Main menu

Advancing clinical metagenomics for patient care in India

  • Published on:

Infectious disease testing is evolving fast, giving researchers the speed and depth they need. This translates into confident decisions and stronger public health surveillance.

In this webinar, Dr Mahua Kapoor (Haystack Analytics) explores how distributed clinical metagenomics can scale across India with insights applicable to healthcare systems worldwide. She shares share practical lessons on integrating next-generation sequencing (NGS) into routine clinical workflows, enabling early and accurate pathogen detection directly from patient samples to close gaps left by conventional microbiology methods.

In this webinar:

  • Discover how targeted NGS enables hypothesis-free, same-day detection of pathogens and antimicrobial resistance genes directly from clinical samples

  • Learn the clinical and economic impact of rapid pathogen identification, including better patient outcomes and lower healthcare costs in low- and middle-income settings

  • Explore how metagenomics delivers real-time, comprehensive workflows with richer insights at scale

Please note: This is independent, investigator-led research using Oxford Nanopore technology. Oxford Nanopore products are for research use only, and not for use in diagnostic procedures.

Authors: Dr Mahua Kapoor, Director Medical Affairs — Infectious Disease (Haystack Analytics) and Harpreet Kukreja, Senior Account Manager, Oxford Nanopore Technologies

入门指南

购买 MinION 启动包 Nanopore 商城 测序服务提供商 全球代理商

联系我们

知识产权 Cookie 政策 企业报告 隐私政策 条件条款 Modern slavery policy 前瞻性陈述

关于 Oxford Nanopore

联系我们 领导团队 媒体资源和联系方式 投资者 在 Oxford Nanopore 工作 BSI 27001 accreditationBSI 90001 accreditation
Chinese flag